Radial Extracorporeal Shock Wave Therapy (rESWT) Treatment of Subacromial Shoulder Pain

Oslo University Hospital150 enrolled

Overview

The purpose of this study is to determine whether rESWT (radial extracorporeal shock wave therapy) combined with supervised exercises will improve function and reduce pain in subacromial shoulder pain compared with supervised exercises alone.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

150

Conditions

Shoulder Impingement Syndrome Subacromial Shoulder Pain

Interventions

Radial extracorporeal shock wave therapyDEVICE

The shockwave treatment will be administered once a week for four weeks on one to three specific points (supraspinatus, infraspinatus or subscapular tendon)and with a pressure between 1,5-3 Bar

Eligibility

Sex: ALLMin age: 25 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Dysfunction or pain on abduction * Pain on one of two isometric tests (abduction or external rotation) * Positive Hawkins sign * Normal passive glenohumeral range of motion Exclusion Criteria: * Previous surgery on affected shoulder * Instability * Total rupture of the rotator cuff (evaluated clinically or by US) * Clinical signs of a cervical syndrome * Infection in the area * Exclusion criteria cont. * Patients considered unable to fill out questionnaires or to go through the treatment * Use of anticoagulant drugs or bleeding disorder * Pregnancy * Previous experience of one of the study interventions * Corticosteroid injection in the past 6 weeks. * SPADI \< 20

Locations (1)

Oslo University Hospital, Ulleval, department for physical medicine and rehabilitation

Oslo, Oslo, Norway

Outcomes

Primary Outcomes

Shoulder Pain and Disability Index (SPADI)

Time frame: 24 weeks

Secondary Outcomes

Health-related quality of life (Eq-5d)

Time frame: 24 weeks and 1 year

Return to work

Time frame: 6 weeks, 12 weeks, 24 weeks and 1 year

Pain and function measured on a 11 point Likert type scale

Time frame: 6 weeks, 12 weeks, 24 weeks and 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.